These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7352114)

  • 1. Extraosseous uptake of 99mtechnetium methylene diphosphonate: neuroblastoma or radiation therapy.
    Sty JR; Kun L; Casper J; Babbitt DP
    Pediatr Radiol; 1980; 9(1):53-4. PubMed ID: 7352114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extraosseous accumulation of (99m)Tc-HMDP to radiation nephropathy, mimicking recurrent neuroblastoma.
    Abe K; Sasaki M; Kuwabara Y; Koga H; Baba S; Kaneko K; Hayashi K; Shioyama Y; Tajiri T; Suita S; Honda H
    Ann Nucl Med; 2005 Feb; 19(1):35-40. PubMed ID: 15770971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary neuroblastoma uptake of 99mtechnetium methylene diphosphonate.
    Smith FW; Gilday DL; Ash JM; Reid RH
    Radiology; 1980 Nov; 137(2):501-4. PubMed ID: 6449027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastatic neuroblastoma: new abnormalities on bone scintigraphy may not indicate tumour recurrence.
    Hall-Craggs MA; Shaw D; Pritchard J; Gordon I
    Skeletal Radiol; 1990; 19(1):33-6. PubMed ID: 2326653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gallium-67 and technetium-99m-methylene diphosphonate skeletal scintigraphy in determining prognosis for children with stage IV neuroblastoma.
    Macdonald WB; Stevens MM; Dalla Pozza L; Bergin M; Menser MA; Howman-Giles R; Uren RF
    J Nucl Med; 1993 Jul; 34(7):1082-6. PubMed ID: 8315482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The complementary role of sequential 99mTc-MDP and 67Ga-citrate scanning in the diagnosis and follow-up of neuroblastoma.
    Garty I; Koren A; Goshen Y; Siplovich L
    Eur J Nucl Med; 1985; 11(6-7):224-9. PubMed ID: 3865771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inconsistency Between Contrast-Enhanced CT and Bone Scintigraphy in Revealing Radiation Nephritis.
    Zhu W; Zhen H; Ding N; Jing H; Huo L
    Clin Nucl Med; 2019 Jun; 44(6):504-506. PubMed ID: 31021909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radionuclide bone scanning in neuroblastoma: skeletal metastases and primary tumor localization of 99mTc-MDP.
    Podrasky AE; Stark DD; Hattner RS; Gooding CA; Moss AA
    AJR Am J Roentgenol; 1983 Sep; 141(3):469-72. PubMed ID: 6224402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skeletal assessment in neuroblastoma--the pitfalls of iodine-123-MIBG scans.
    Gordon I; Peters AM; Gutman A; Morony S; Dicks-Mireaux C; Pritchard J
    J Nucl Med; 1990 Feb; 31(2):129-34. PubMed ID: 2313350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extraosseous uptake of technetium-99m MDP in secondary deposits of neuroblastoma.
    Mandell GA; Heyman S
    Clin Nucl Med; 1986 May; 11(5):337-40. PubMed ID: 3698433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 99mTc-methylene diphosphonate imaging in neural crest tumors.
    Sty JR; Babbitt DP; Casper JT; Boedecker RA
    Clin Nucl Med; 1979 Jan; 4(1):12-7. PubMed ID: 421393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of bone-marrow scanning with technetium-99m sulfur colloid in pediatric oncology.
    Siddiqui AR; Oseas RS; Wellman HN; Doerr DR; Baehner RL
    J Nucl Med; 1979 May; 20(5):379-86. PubMed ID: 232146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does I-131-MIBG underestimate skeletal disease burden in neuroblastoma?
    Barai S; Bandopadhayaya GP; Malhotra A; Agarwal S; Kumar R; Dhanapathi H
    J Postgrad Med; 2004; 50(4):257-60; discussion 260-1. PubMed ID: 15623965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the utility of
    Gauguet JM; Pace-Emerson T; Grant FD; Shusterman S; DuBois SG; Frazier AL; Voss SD
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28449267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iodine-131-metaiodobenzylguanidine and bone scintigraphy for the detection of neuroblastoma.
    Shulkin BL; Shapiro B; Hutchinson RJ
    J Nucl Med; 1992 Oct; 33(10):1735-40. PubMed ID: 1403138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging and treatment of disseminated neuroblastoma with 131I-meta-iodobenzylguanidine.
    Gerrard M; Eden OB; Merrick MV
    Br J Radiol; 1987 Apr; 60(712):393-5. PubMed ID: 3580745
    [No Abstract]   [Full Text] [Related]  

  • 17. Abdominal masses in children: multiorgan imaging with 99mTc methylene diphosphonate.
    Siddiqui AR; Cohen M; Moran DP
    AJR Am J Roentgenol; 1982 Jul; 139(1):35-8. PubMed ID: 6283869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The changes in renal uptake of 99mTc-MDP after radiotherapy in the neuroblastoma (author's transl)].
    Takebayashi S; Ono Y; Matsui K
    Kaku Igaku; 1981 Jul; 18(6):859-62. PubMed ID: 6458719
    [No Abstract]   [Full Text] [Related]  

  • 19. [The place of 99mTc-MDP skeletal scintigraphy in neuroblastoma. Is a new assessment necessary?].
    Sautter-Bihl ML; Bihl H; Heinze HG
    Nuklearmedizin; 1991 Feb; 30(1):7-12. PubMed ID: 2062676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of stage 4 neuroblastoma patients by means of MIBG and 99mTc-MDP scintigraphy.
    Turba E; Fagioli G; Mancini AF; Rosito P; Galli A; Alvisi P
    J Nucl Biol Med (1991); 1993 Sep; 37(3):107-14. PubMed ID: 8218456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.